Jaffetilchin Investment Partners LLC purchased a new position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 8,696 shares of the real estate investment trust’s stock, valued at approximately $277,000. Jaffetilchin Investment Partners LLC owned approximately 4,390.37% of Omega Healthcare Investors at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in OHI. World Asset Management Inc grew its stake in Omega Healthcare Investors by 0.8% in the 2nd quarter. World Asset Management Inc now owns 15,257 shares of the real estate investment trust’s stock valued at $504,000 after purchasing an additional 118 shares during the period. First Heartland Consultants Inc. grew its stake in Omega Healthcare Investors by 1.0% in the 2nd quarter. First Heartland Consultants Inc. now owns 18,187 shares of the real estate investment trust’s stock valued at $601,000 after purchasing an additional 175 shares during the period. BKS Advisors LLC grew its stake in Omega Healthcare Investors by 2.7% in the 2nd quarter. BKS Advisors LLC now owns 7,715 shares of the real estate investment trust’s stock valued at $255,000 after purchasing an additional 200 shares during the period. Meridian Investment Counsel Inc. grew its stake in Omega Healthcare Investors by 0.7% in the 2nd quarter. Meridian Investment Counsel Inc. now owns 35,164 shares of the real estate investment trust’s stock valued at $1,161,000 after purchasing an additional 250 shares during the period. Finally, Naples Global Advisors LLC grew its stake in Omega Healthcare Investors by 1.9% in the 2nd quarter. Naples Global Advisors LLC now owns 15,102 shares of the real estate investment trust’s stock valued at $499,000 after purchasing an additional 275 shares during the period. Institutional investors and hedge funds own 72.33% of the company’s stock.

Omega Healthcare Investors, Inc. (NYSE:OHI) opened at $28.05 on Friday. The company has a debt-to-equity ratio of 1.18, a quick ratio of 3.04 and a current ratio of 3.40. The firm has a market capitalization of $5,557.94, a price-to-earnings ratio of 8.25, a PEG ratio of 2.92 and a beta of 0.53. Omega Healthcare Investors, Inc. has a 12 month low of $27.32 and a 12 month high of $35.14.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, November 15th. Stockholders of record on Tuesday, October 31st will be paid a dividend of $0.65 per share. This is an increase from Omega Healthcare Investors’s previous quarterly dividend of $0.64. The ex-dividend date of this dividend is Monday, October 30th. This represents a $2.60 annualized dividend and a dividend yield of 9.27%. Omega Healthcare Investors’s dividend payout ratio is presently 317.08%.

ILLEGAL ACTIVITY NOTICE: “Jaffetilchin Investment Partners LLC Purchases Shares of 8,696 Omega Healthcare Investors, Inc. (OHI)” was first published by Watch List News and is owned by of Watch List News. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The original version of this news story can be viewed at https://www.watchlistnews.com/jaffetilchin-investment-partners-llc-purchases-shares-of-8696-omega-healthcare-investors-inc-ohi/1695955.html.

In other news, Director Bernard J. Korman purchased 100,000 shares of the business’s stock in a transaction dated Tuesday, October 31st. The stock was bought at an average price of $28.24 per share, for a total transaction of $2,824,000.00. Following the purchase, the director now owns 903,895 shares of the company’s stock, valued at $25,525,994.80. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Craig R. Callen purchased 10,000 shares of the business’s stock in a transaction dated Thursday, November 2nd. The shares were purchased at an average price of $27.38 per share, with a total value of $273,800.00. The disclosure for this purchase can be found here. 1.54% of the stock is currently owned by corporate insiders.

A number of research analysts have issued reports on the company. ValuEngine downgraded Omega Healthcare Investors from a “buy” rating to a “hold” rating in a research note on Wednesday, September 6th. Jefferies Group LLC restated a “hold” rating and issued a $30.00 price objective on shares of Omega Healthcare Investors in a research note on Tuesday, October 3rd. Vetr downgraded Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $33.33 price objective for the company. in a research note on Thursday, October 19th. BidaskClub downgraded Omega Healthcare Investors from a “hold” rating to a “sell” rating in a research note on Saturday, August 5th. Finally, Zacks Investment Research upgraded Omega Healthcare Investors from a “sell” rating to a “hold” rating in a research note on Thursday, August 3rd. One analyst has rated the stock with a sell rating, six have assigned a hold rating and two have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $31.83.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.